News
A different study presented at the 2025 ASCO Annual Meeting showed that one specific diet may benefit people with colon ...
Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with RAS/MAPK ...
Pfizer Inc. (NYSE: PFE) announced today the completion of a global, ex-China, licensing agreement with 3SBio, Inc. (01530.HK) ...
The biologic and biosimilar era has brought about more clinical trials in rheumatology than ever before, and with increasing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results